Accellient Partners
Biotechnology Research • 
Waltham, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 1000 Winter Street, Suite 2000, Waltham, MA, US |
| Phone number | +19785024038 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Drug Development, Fda Submissions, Biopharmaceutical Product Development, Regulatory Consulting & Compliance |
| Founded | 2010 |
| Employees | 1-10 |
| Socials |
Key Contact at Accellient Partners
Bill Kerns
Ceo
Accellient Partners Email Formats
Accellient Partners uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@accellient.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@accellient.com | 100% |
About Accellient Partners
Accellient Partners is a fully integrated and dedicated team of drug development experts with broad drug development, regulatory and scientific experience. Our team designs, implements and manages all product development needs for biotech co's. Accellient’s development model leverages know-how, technology and business experience to; Minimize program risks and lower costs; Accelerate development timelines via tailored development plans; Achieve targeted milestones to improve return on investment; and Assist in the capital raising process. We develop and manage programs from late discovery through IND submission and Phase 2. We also continue to support the manufacturing requirements and nonclinical development needs of projects through the complex registration process. Our approach enables business leaders and investors to fully assess all risk factors and their impact on success to support major investment and infrastructure decisions. Accellient partners with clients in all markets. We provide core technical drug development expertise and an extensive network of expert affiliates, KOL's and proven service providers that complement your discovery, development and management team. We are currently filing electronic INDs quarterly and have significant experience working with all divisions of the FDA. Accellient offers an efficient and cost effective approach and strives to be the biopharmaceutical and investment industries’ virtual drug development partner of choice.
Accellient Partners revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Accellient Partners has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
Accellient Partners has never raised funding before.
Accellient Partners Tech Stack
Discover the technologies and tools that power Accellient Partners's digital infrastructure, from frameworks to analytics platforms.
Hosting
South Africa
Spain
Australia
Frequently asked questions
4.8
40,000 users
